MOSAIQ® Oncology Information System and Sequencer MOSAIQ is an oncology information system used to manage workflows for treatment planning and delivery. It supports information flow among healthcare facility personnel and can be used wherever radiotherapy and/or chemotherapy are prescribed.
Published February 20, 2019 · Recall initiated: December 13, 2018
Summary
FDA records medical device Class II recall Z-0821-2019, published February 20, 2019 and initiated December 13, 2018. Recalling firm: Elekta, Inc.; Status: Ongoing; Reported quantity: 3,950 units total (1,747 US); Lot: MOSAIQ Radiation Oncology version 1.0 and higher. Multi-ACCESS version 6.1 and higher. UDI 858164002084 858164002091 858164002107 858164002220 858164002237. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a potential that Wedge IDs were not included in the DICOM RT PLAN sent from the TPS, which will cause the field in MOSAIQ to be created with no wedge. Treatment of a field without the planned wedge will receive more dose than the treatment plan indicates.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Elekta, Inc.
- Distributor
- U.S. Nationwide distribution to the following states AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY and the District of Columbia and Puerto Rico.
- Lot
- MOSAIQ Radiation Oncology version 1.0 and higher. Multi-ACCESS version 6.1 and higher. UDI 858164002084 858164002091 858164002107 858164002220 858164002237
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABrand Name: Fletcher CT/MR Shielded Applicator Set Product Name: Intracavitary Remote Afterloading ApplicatorJuly 15, 2026
- FDABrand Name: Geneva Product Name: Brachytherapy Applicator Product Description: The device is intended forJuly 15, 2026
- FDABrand Name: Brachytherapy Applicator Product Name: Advanced Gynecological Applicator Product Description: TheJuly 15, 2026
- FDAMOSAIQ Oncology Information SystemJune 17, 2026
- FDAMedtronic implantable pulse generator: RELIA, Dual chamber pacemaker (VDD): (a) Model Number RED01 (b) ModelFebruary 20, 2019
- FDA21Y15 MagValve Product Usage: The PushValves/ MagValves is intended exclusively for the prosthetic fitting ofFebruary 20, 2019
Questions about this recall
Was MOSAIQ® Oncology Information System and Sequencer MOSAIQ is an oncology information system used to manage workflows for treatment planning and delivery. It supports information flow among healthcare facility personnel and can be used wherever radiotherapy and/or chemotherapy are prescribed. recalled?
Yes. FDA published recall Z-0821-2019 on February 20, 2019. Reported hazard: There is a potential that Wedge IDs were not included in the DICOM RT PLAN sent from the TPS, which will cause the field in MOSAIQ to be created with no wedge. Treatment of a field without the planned wedge will receive more dose than the treatment plan indicates.
What should I do if I have this product?
Voluntary: Firm initiated · Letter